These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8563834)

  • 1. Sensitivity analysis in economic evaluation: a review of published studies.
    Briggs A; Sculpher M
    Health Econ; 1995; 4(5):355-71. PubMed ID: 8563834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who's better not best: appropriate probabilistic uncertainty analysis.
    Coyle D
    Int J Technol Assess Health Care; 2003; 19(3):540-5. PubMed ID: 12962341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical approaches to handling uncertainty in health economic evaluation.
    Briggs AH
    Eur J Gastroenterol Hepatol; 2004 Jun; 16(6):551-61. PubMed ID: 15167156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and interpretation of cost data in randomised controlled trials: review of published studies.
    Barber JA; Thompson SG
    BMJ; 1998 Oct; 317(7167):1195-200. PubMed ID: 9794854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sepsis: the LightCycler SeptiFast Test MGRADE®, SepsiTest™ and IRIDICA BAC BSI assay for rapidly identifying bloodstream bacteria and fungi - a systematic review and economic evaluation.
    Stevenson M; Pandor A; Martyn-St James M; Rafia R; Uttley L; Stevens J; Sanderson J; Wong R; Perkins GD; McMullan R; Dark P
    Health Technol Assess; 2016 Jun; 20(46):1-246. PubMed ID: 27355222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In search of power and significance: issues in the design and analysis of stochastic cost-effectiveness studies in health care.
    O'Brien BJ; Drummond MF; Labelle RJ; Willan A
    Med Care; 1994 Feb; 32(2):150-63. PubMed ID: 8302107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth and quality of the cost-utility literature, 1976-2001.
    Neumann PJ; Greenberg D; Olchanski NV; Stone PW; Rosen AB
    Value Health; 2005; 8(1):3-9. PubMed ID: 15841889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials.
    Doshi JA; Glick HA; Polsky D
    Value Health; 2006; 9(5):334-40. PubMed ID: 16961551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
    Barbieri M; Drummond M; Willke R; Chancellor J; Jolain B; Towse A
    Value Health; 2005; 8(1):10-23. PubMed ID: 15841890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis.
    Walker D; Fox-Rushby J
    Health Policy Plan; 2001 Dec; 16(4):435-43. PubMed ID: 11739369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and quality assessment of economic evaluation studies of injury prevention.
    Polinder S; Segui-Gomez M; Toet H; Belt E; Sethi D; Racioppi F; van Beeck EF
    Accid Anal Prev; 2012 Mar; 45():211-21. PubMed ID: 22269503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic evaluation.
    Drummond MF; Aguiar-Ibanez R; Nixon J
    Singapore Med J; 2006 Jun; 47(6):456-61; quiz 462. PubMed ID: 16752012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing a portfolio of health care programs in the presence of uncertainty and constrained resources.
    Sendi P; Al MJ; Gafni A; Birch S
    Soc Sci Med; 2003 Dec; 57(11):2207-15. PubMed ID: 14512250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Searching literature databases for health care economic evaluations: how systematic can we afford to be?
    Sassi F; Archard L; McDaid D
    Med Care; 2002 May; 40(5):387-94. PubMed ID: 11961473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity analysis for handling uncertainty in an economic evaluation.
    Limwattananon S
    J Med Assoc Thai; 2014 May; 97 Suppl 5():S59-64. PubMed ID: 24964700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic value of out-of-hospital emergency care: a structured literature review.
    Lerner EB; Maio RF; Garrison HG; Spaite DW; Nichol G
    Ann Emerg Med; 2006 Jun; 47(6):515-24. PubMed ID: 16713777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness-to-pay (WTP): the new-old kid on the economic evaluation block.
    Gafni A
    Can J Nurs Res; 2001 Jun; 33(1):59-64. PubMed ID: 11928155
    [No Abstract]   [Full Text] [Related]  

  • 19. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis.
    Briggs A; Sculpher M; Buxton M
    Health Econ; 1994; 3(2):95-104. PubMed ID: 8044216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.